ALTERITY THERAPEUTICS-ADR (ATHE) Stock Analyst Earnings Estimates
NASDAQ:ATHE - Nasdaq - US02155X2053 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 2.5K -87.91% | 16.44K 557.60% | 268.42K 1,532.73% | |
| EBITDA YoY % growth | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.954M -3.79% | -14.622M 8.35% | -19.339M -32.26% | |
| Operating Margin | -638,144.40% | -88,940.45% | -7,204.58% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in AUD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in AUD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 150.02K 2,864.82% | % | ||
| Q2 2024 Q2Q % growth | 118.4K 940.42% | % | ||
| Q4 2023 Q2Q % growth | 5.06K 340.00% | % | ||
| Q2 2023 Q2Q % growth | 11.38K 742.96% | % | ||
| Q4 2022 Q2Q % growth | 1.15K -91.86% | % | ||
| Q2 2022 Q2Q % growth | 1.35K -79.39% | % | ||
| Q4 2021 Q2Q % growth | 14.12K 373.83% | % | ||
| Q2 2021 Q2Q % growth | 6.55K -53.64% | % | ||
| Q4 2020 Q2Q % growth | 2.98K -92.93% | % | ||
| Q2 2020 Q2Q % growth | 14.13K -78.71% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |